Search
Novartis AG
NVSAdd to Watchlist
162.550USD
+0.620+0.38%
Close 11-06 16:00（ET）
308.96BMarket Cap
23.16P/E TTM
After-hours 19:00 (ET)162.550USD-0.160-0.10%
After-hours 19:00 (ET)Novartis AG (NVS) Stock Price Target & Forecast
Analyst Rating
Based on 11 analysts giving stock ratings to Novartis AG in the past month.
Hold
1 Strong Buy
3 Buy
5 Hold
2 Sell
0 Strong Sell
Target Price
153.861USD-4.31%
NVS Analyst Recommendation Trends
In the current month, NVS has received 3 Buy Ratings, 5 Hold Ratings, and 2 Sell Ratings. NVS average Analyst price target in the last month is 153.861.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
1
1
1
1
1
1
1
1
3
3
2
2
2
2
2
2
5
5
4
4
4
4
4
4
0
0
0
0
0
0
0
0
2
2
3
3
3
3
3
3
11
11
10
10
10
10
10
10
NVS Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
8
16
12
1
0
37
Amgen Inc
AMGN
4
9
19
3
1
36
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Eli Lilly and Co
LLY
10
19
3
1
0
33
Alnylam Pharmaceuticals Inc
ALNY
7
17
8
0
0
32
AbbVie Inc
ABBV
8
18
6
0
0
32
Merck & Co Inc
MRK
7
16
8
0
0
31
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Bristol-Myers Squibb Co
BMY
5
6
18
1
0
30
Gilead Sciences Inc
GILD
7
18
5
0
0
30
Financial Forecasting
Based on analysts' estimates, NVS EPS is projected to reach 2.263 in FY2026Q4, following reported EPS of 0.634 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
2.08
2.36
2.29
2.26
2.30
Actual
1.65
1.71
0.63
--
--
Surprise
-20.71%
-27.34%
-72.35%
--
--
FAQs
What is Novartis AG's expected revenue for the next quarter?
Novartis AG's expected revenue is 14.68B.
What is Novartis AG's price target?
Analysts forecast that Novartis AG's price target is USD 153.86, with the highest forecast at USD 185.00 and the lowest forecast at USD 120.79.
How have Novartis AGNVS's recent earnings per share performed?
The market expectation was USD 0.63, while Novartis AGNVS's earnings per share (EPS) for the previous quarter was USD 1.71. EPS for the next quarter is expected at USD 2.26.
What is the analyst rating for Novartis AG?
Based on the ratings of Novartis AG's stock from 11 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.